This enhanced ADCC, which was observed regardless of the tumor’s KRAS mutation status, is linked to a restoration of the apoptotic cascade, evidenced by a rise in caspase-3/7 activity and a reduction in the anti-apoptotic protein Bcl-2 (Gomes et al., 2016). The gene discussed is KRAS; the disease is neoplasm.